Abstract

Secreted levels of HSP90α and overexpression of TCF12 have been associated with the enhancement of colorectal cancer (CRC) cell migration and invasion. In this study, we observed that CRC patients with tumor TCF12 overexpression exhibited both a higher rate of metastatic occurrence and a higher average serum HSP90α level compared with patients without TCF12 overexpression. Therefore, we studied the relationship between the actions of secreted HSP90α and TCF12. Like overexpressed TCF12, secreted HSP90α or recombinant HSP90α (rHSP90α) induced fibronectin expression and repressed E-cadherin, connexin-26, connexin-43, and gap junction levels in CRC cells. Consistently, rHSP90α stimulated invasive outgrowths of CRC cells from spherical structures during three-dimensional culture. rHSP90α also induced TCF12 expression in CRC cells. Its effects on CRC cell epithelial-mesenchymal transition, migration, and invasion were drastically prevented when TCF12 was knocked down. This suggests that TCF12 expression is required for secreted HSP90α to enhance CRC cell spreading. Through the cellular receptor CD91, rHSP90α facilitated the complex formation of CD91 with IκB kinases (IKKs) α and β and increased the levels of phosphorylated (active) IKKα/β and NF-κB. Use of an IKKα/β inhibitor or ectopic overexpression of dominant-negative IκBα efficiently repressed rHSP90α-induced TCF12 expression. Moreover, κB motifs were recognized in the gene sequence of the TCF12 promoter, and a physical association between NF-κB and the TCF12 promoter was detected in rHSP90α-treated CRC cells. Together, these results suggest that the CD91/IKK/NF-κB signaling cascade is involved in secreted HSP90α-induced TCF12 expression, leading to E-cadherin down-regulation and enhanced CRC cell migration/invasion.

Highlights

  • Both secreted HSP90␣ and overexpressed TCF12 enhance colorectal cancer (CRC) cell migration/invasion

  • Our results reveal that a CD91/I␬B kinase (IKK)/ NF-␬B signaling cascade is involved in secreted HSP90␣-induced TCF12 expression, which in turn results in E-cadherin down-regulation and enhanced CRC cell migration/invasion

  • In parallel with the result we reported previously, a higher average serum HSP90␣ level was detected in patients with metastasis compared with those without metastasis, the difference between the two groups was not statistically significant (333.2 Ϯ 157.0 versus 263.0 Ϯ 124.3 ␮g/ml, p ϭ 0.058) (Fig. 1A)

Read more

Summary

Background

Both secreted HSP90␣ and overexpressed TCF12 enhance colorectal cancer (CRC) cell migration/invasion. Upon knockdown or ectopic overexpression in CRC cell lines, TCF12 was associated with cellular epithelial-mesenchymal transition (EMT) by inducing fibronectin expression and repressing E-cadherin, connexin-26, connexin-43, and gap junction levels. It facilitated CRC cell migration, invasion, and metastasis [11]. Like TCF12 overexpression, cellular secreted HSP90␣ and recombinant HSP90␣ (rHSP90␣) induced fibronectin expression but repressed E-cadherin, connexin-26, connexin-43, and gap junction levels in CRC cells. Our results reveal that a CD91/I␬B kinase (IKK)/ NF-␬B signaling cascade is involved in secreted HSP90␣-induced TCF12 expression, which in turn results in E-cadherin down-regulation and enhanced CRC cell migration/invasion

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call